Menu
Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 16
RETRACTED ARTICLE: The Mechanism of Penehyclidine Hydrochloride and Its Effect on the Inflammatory Response of Lung Tissue in Rats with Chronic Obstructive Pulmonary Disease During Mechanical Ventilation
Authors Chen Z, Zhang Y, Wu J, Gao X, Huang C, Lin Y, Xu X, Li Y
Received 2 December 2020
Accepted for publication 11 March 2021
Published 31 March 2021 Volume 2021:16 Pages 877—885
DOI https://doi.org/10.2147/COPD.S295329
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Richard Russell
This paper has been retracted.
Chen Z, Zhang Y, Wu J, et al. Int J Chron Obstruct Pulmon Dis. 2021;16:877–885.
The Editor and Publisher of International Journal of Chronic Obstructive Pulmonary Disease are retracting the published article. Concerns were raised that the western blot results in Figure 4 had been duplicated with those from Figure 6 in Liu CY, Wu JH, Chen ZY, Zhang Y, Huang CL, Lin AM, Xu XT, Gao XH. Effect of Doxofylline on Reducing the Inflammatory Response in Mechanically Ventilated Rats with Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2021;16:2375—2383, https://doi.org/10.2147/COPD.S315639. Both sets of western blots are describing results from different studies.
The authors did not respond to our queries and as the findings could not be verified the Editor and Publisher made the decision to retract the article. The authors were notified of this decision.
We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.